Clinical Research Regulation For Brazil | ClinRegs
Overview. As per ResNo9, ResNo61, and ResNo176, the National Health Surveillance Agency (Agência Nacional de Vigilância Sanitária (ANVISA)) is the regulatory authority responsible for clinical trial oversight, approval, and inspection of drugs to be registered in Brazil. ANVISA grants permission for clinical trials to be conducted in accordance with the provisions of ResNo9, ResNo61, and ...
DA: 86 PA: 89 MOZ Rank: 99